It indicated that targeting individual components of this pathway, such as PI3K, phosphoinositide-dependent kinase-1 (PDK-1), Akt, and mTOR (mammalian Target of Rapamycin), may be a possible cancer therapy technique (Asati et al., 2016). This evidence concerns the gene MTOR and cancer.